1. Home
  2. BTG vs BIO Comparison

BTG vs BIO Comparison

Compare BTG & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BTG
  • BIO
  • Stock Information
  • Founded
  • BTG 2006
  • BIO 1952
  • Country
  • BTG Canada
  • BIO United States
  • Employees
  • BTG N/A
  • BIO N/A
  • Industry
  • BTG Precious Metals
  • BIO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • BTG Basic Materials
  • BIO Industrials
  • Exchange
  • BTG Nasdaq
  • BIO Nasdaq
  • Market Cap
  • BTG 6.6B
  • BIO 7.7B
  • IPO Year
  • BTG N/A
  • BIO N/A
  • Fundamental
  • Price
  • BTG $5.26
  • BIO $297.20
  • Analyst Decision
  • BTG Buy
  • BIO Strong Buy
  • Analyst Count
  • BTG 2
  • BIO 4
  • Target Price
  • BTG $4.50
  • BIO $333.50
  • AVG Volume (30 Days)
  • BTG 56.6M
  • BIO 214.4K
  • Earning Date
  • BTG 11-05-2025
  • BIO 10-29-2025
  • Dividend Yield
  • BTG 1.91%
  • BIO N/A
  • EPS Growth
  • BTG N/A
  • BIO N/A
  • EPS
  • BTG N/A
  • BIO 11.49
  • Revenue
  • BTG $2,172,330,000.00
  • BIO $2,554,200,000.00
  • Revenue This Year
  • BTG $69.24
  • BIO $2.12
  • Revenue Next Year
  • BTG $8.36
  • BIO $2.90
  • P/E Ratio
  • BTG N/A
  • BIO $25.93
  • Revenue Growth
  • BTG 11.75
  • BIO N/A
  • 52 Week Low
  • BTG $2.20
  • BIO $211.43
  • 52 Week High
  • BTG $5.40
  • BIO $387.99
  • Technical
  • Relative Strength Index (RSI)
  • BTG 76.93
  • BIO 58.13
  • Support Level
  • BTG $4.85
  • BIO $266.71
  • Resistance Level
  • BTG $5.40
  • BIO $286.84
  • Average True Range (ATR)
  • BTG 0.16
  • BIO 8.86
  • MACD
  • BTG 0.03
  • BIO 2.64
  • Stochastic Oscillator
  • BTG 87.07
  • BIO 71.98

About BTG B2Gold Corp Common shares (Canada)

B2Gold Corp is an international, low-cost, senior gold mining company. It has three operating open-pit gold mines in Mali, Namibia, and the Philippines and numerous exploration projects across four continents. Other assets include the Gramalote and Kiaka gold projects. The company focuses on acquiring and developing interests in mineral properties with a primary focus on gold deposits as gold production forms all its revenue. There is no dependence on a particular purchaser because the gold is sold into various markets. The company's reportable operating segments include its mining operations and development projects, namely Fekola; Masbate; Otjikoto; the Goose Project, and other mineral properties; and corporate and other.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: